Evidence map›Paper›PMID 39480564›Full record

ArticleInsights into imaging2024

A quantitative model using multi-parameters in dual-energy CT to preoperatively predict serosal invasion in locally advanced gastric cancer.

Yiyang Liu, Mengchen Yuan, Zihao Zhao, Shuai Zhao, Xuejun Chen, Yang Fu, Mengwei Shi, Diansen Chen, Zongbin Hou, Yongqiang Zhang and 8 more

Abstract read
In one paragraph

Article in Insights into imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yiyang Liu *Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Mengchen Yuan *Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zihao Zhao *Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Shuai ZhaoDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Xuejun ChenDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, 450008, China.
Yang FuDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou, University, Zhengzhou, 450052, China.
Mengwei ShiDepartment of Radiology, The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, 014030, China.
Diansen ChenDepartment of Radiology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471003, China.
Zongbin HouDepartment of Radiology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471003, China.
Yongqiang ZhangCT Diagnostic Center, Sanmenxia Central Hospital, Sanmenxia, 472000, China.
Juan DuCT Diagnostic Center, Sanmenxia Central Hospital, Sanmenxia, 472000, China.
Yinshi ZhengMedical Imaging Center, The First People's Hospital of Shangqiu City, Shangqiu, 476100, China.
Luhao LiuCollege of Acupuncture and Massage, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Yiming LiMedical Imaging Center, The First People's Hospital of Shangqiu City, Shangqiu, 476100, China.
Beijun GaoDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Qingyu JiDepartment of Radiology, The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, 014030, China. jiqingyusci@163.com.
Jing LiDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, 450008, China. lijingqingqing@163.com.
Jianbo GaoDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. cjr.gaojianbo@vip.163.com.ORCID http://orcid.org/0000-0002-6844-130X

Funding

Medical Science and Technology Innovation Award Project of Henan Academy of Medical Sciences 0010
6 · The paper itself

Abstract

objectivesTo develop and validate a quantitative model for predicting serosal invasion based on multi-parameters in preoperative dual-energy CT (DECT). MATERIALS AND

methodsA total of 342 LAGC patients who underwent gastrectomy and DECT from six centers were divided into one training cohort (TC), and two validation cohorts (VCs). Dual-phase enhanced DECT-derived iodine concentration (IC), water concentration, and monochromatic attenuation of lesions, along with clinical information, were measured and collected. The independent predictors among these characteristics for serosal invasion were screened with Spearman correlation analysis and logistic regression (LR) analysis. A quantitative model was developed based on LR classifier with fivefold cross-validation for predicting the serosal invasion in LAGC. We comprehensively tested the model and investigated its value in survival analysis.

resultsA quantitative model was established using IC, 70 keV, 100 keV monochromatic attenuations in the venous phase, and CT-reported T4a, which were independent predictors of serosal invasion. The proposed model had the area-under-the-curve (AUC) values of 0.889 for TC and 0.860 and 0.837 for VCs. Subgroup analysis showed that the model could well discriminate T3 from T4a groups, and T2 from T4a groups in all cohorts (all p < 0.001). Besides, disease-free survival (DFS) (TC, p = 0.015; and VC1, p = 0.043) could be stratified using this quantitative model.

conclusionThe proposed quantitative model using multi-parameters in DECT accurately predicts serosal invasion for LAGC and showed a significant correlation with the DFS of patients. CRITICAL RELEVANCE STATEMENT: This quantitative model from dual-energy CT is a useful tool for predicting the serosal invasion of locally advanced gastric cancer. KEY POINTS: Serosal invasion is a poor prognostic factor in locally advanced gastric cancer that may be predicted by DECT. DECT quantitative model for predicting serosal invasion was significantly and positively correlated with pathologic T stages. This quantitative model was associated with patient postoperative disease-free survival.

Indexed as

Dual-energy CTMulti-parametersSerosal invasionX-ray computed

Identifiers

PMID39480564
PMCPMC11528085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.